Biologica Technologies entered two significant, separate agreements with Premier and Academy Medical. Biologica Technologies markets ProteiOS growth factor and OsseoGEN cellular bone matrix.
With Premier, Biologica has been awarded a Bone and Bone Substitute Implantable Product group purchasing agreement, allowing Premier members to access special pricing and terms pre-negotiated by Premier for the company’s ProteiOS, OsseoGEN and ProGraft product lines.
In addition, Biologica has partnered with Academy Medical, a Service-Disabled Veteran-Owned Small Business, to access the full complement of Veterans Administration Hospitals across the country.
Premier is a healthcare improvement company uniting an alliance of approximately 4,400 U.S. hospitals and health systems and more than 250,000 other providers and organizations.
Biologica Technologies entered two significant, separate agreements with Premier and Academy Medical. Biologica Technologies markets ProteiOS growth factor and OsseoGEN cellular bone matrix.
With Premier, Biologica has been awarded a Bone and Bone Substitute Implantable Product group purchasing agreement, allowing Premier members to access...
Biologica Technologies entered two significant, separate agreements with Premier and Academy Medical. Biologica Technologies markets ProteiOS growth factor and OsseoGEN cellular bone matrix.
With Premier, Biologica has been awarded a Bone and Bone Substitute Implantable Product group purchasing agreement, allowing Premier members to access special pricing and terms pre-negotiated by Premier for the company’s ProteiOS, OsseoGEN and ProGraft product lines.
In addition, Biologica has partnered with Academy Medical, a Service-Disabled Veteran-Owned Small Business, to access the full complement of Veterans Administration Hospitals across the country.
Premier is a healthcare improvement company uniting an alliance of approximately 4,400 U.S. hospitals and health systems and more than 250,000 other providers and organizations.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
